Literature DB >> 8640347

Differential effects of fibrates on the acyl composition of microsomal phospholipids in rats.

M Vázquez1, S Muñoz, M Alegret, T Adzet, M Merlos, J C Laguna.   

Abstract

1. The time-course and comparative effects of treatment with clofibrate (CFB), bezafibrate (BFB), and gemfibrozil (GFB) on the acyl composition of the main microsomal phospholipids, i.e. phosphatidylcholine and phosphatidylethanolamine, have been studied in male Sprague-Dawley rats. 2. The administration of the three fibrates caused a strong peroxisomal induction and a hypolipidaemic effect. Concerning the changes in acyl composition, CFB and BFB behaved in a similar way, with differences which could be attributed to their different potency as peroxisome inducers, whereas GFB showed a somewhat distinct profile. 3. The three drugs increased the relative content of palmitic, palmitoleic and oleic acids, whereas the levels of stearic acid and also those of long chain, highly unsaturated fatty acids docosatetraenoic, docosapentaenoic and docosahexaenoic acids were reduced. In general, these effects appeared from the first day of treatment and were highly correlated with peroxisomal proliferation. In addition, they were more evident in the phosphatidylcholine than in the phosphatidylethanolamine fraction. 4. Fibrates increased total monounsaturated fatty acids, whereas a decrease in total polyunsaturated fatty acids in the phosphatidylcholine fraction was observed in CFB- and BFB-, but not in GFB-treated rats. Clear differences appeared between CFB and BFB on the one hand, and GFB on the other when the influence of fibrate treatment on the molar percentages of linoleic, eicosatrienoic, arachidonic and mead acids was analyzed. 5. GFB increased linoleic acid content in phosphatidylethanolamine, whereas CFB and BFB decreased its level in both phospholipid fractions. In contrast, CFB and BFB enhanced eicosatrienoic and mead acids in both fractions and arachidonic acid in phosphatidylethanolamine, whereas GFB had practically no effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8640347      PMCID: PMC1908928          DOI: 10.1111/j.1476-5381.1995.tb16413.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 2.  The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney.

Authors:  J M Hawkins; W E Jones; F W Bonner; G G Gibson
Journal:  Drug Metab Rev       Date:  1987       Impact factor: 4.518

Review 3.  Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man.

Authors:  M N Cayen
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

4.  Assay of peroxisomal beta-oxidation of fatty acids.

Authors:  P B Lazarow
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Species differences in hepatic peroxisome proliferation.

Authors:  B G Lake; T J Gray
Journal:  Biochem Soc Trans       Date:  1985-10       Impact factor: 5.407

Review 6.  Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.

Authors:  P A Todd; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

Review 7.  Lipid-lowering drugs. An overview of indications and optimum therapeutic use.

Authors:  D R Illingworth
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

Review 8.  Chemistry, biochemistry, and pharmacology of HMG-CoA reductase inhibitors.

Authors:  A Endo
Journal:  Klin Wochenschr       Date:  1988-05-16

9.  Essential fatty acid deficiency lowers the activity of the acetylated low density lipoprotein receptor of rat peritoneal macrophages.

Authors:  G R Gavino; E Levy; V C Gavino
Journal:  Biochem Cell Biol       Date:  1992 Mar-Apr       Impact factor: 3.626

10.  Modification by clofibric acid of acyl composition of glycerolipids in rat liver. Possible involvement of fatty acid chain elongation and desaturation.

Authors:  Y Kawashima; A Hirose; H Kozuka
Journal:  Biochim Biophys Acta       Date:  1984-10-04
View more
  5 in total

1.  Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition.

Authors:  M Vázquez; M Merlos; T Adzet; J C Laguna
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

2.  Different effects of fibrates on the microsomal fatty acid chain elongation and the acyl composition of phospholipids in guinea-pigs.

Authors:  M Vázquez; M Alegret; M López; C Rodríguez; T Adzet; M Merlos; J C Laguna
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 3.  On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

4.  Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.

Authors:  M Vázquez; D Zambón; Y Hernández; T Adzet; M Merlos; E Ros; J C Laguna
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

5.  Bezafibrate induces acyl-CoA oxidase mRNA levels and fatty acid peroxisomal beta-oxidation in rat white adipose tissue.

Authors:  M Vázquez; N Roglans; A Cabrero; C Rodríguez; T Adzet; M Alegret; R M Sánchez; J C Laguna
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.